Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1149760 | 0.81 | TSHR (0.37) | TSHRLMNARAB9AHSP90AA1HSP90AB1 | |
| SCHEMBL296460 | 0.80 | TSHR (0.33) | TSHRLMNARAB9AHSP90AA1HSP90AB1 | |
| SCHEMBL2127418 | 0.79 | LMNA (0.51) | TSHRLMNARAB9AALDH1A1 | |
| SCHEMBL7641129 | 0.79 | TSHR (0.39) | TSHRLMNARAB9AHSP90AA1HSP90AB1 | |
| SCHEMBL2128973 | 0.78 | TSHR (0.38) | TSHRLMNAALDH1A1 | |
| SCHEMBL2128447 | 0.76 | LMNA (0.38) | TSHRLMNAALDH1A1 | |
| SCHEMBL2129276 | 0.75 | ALDH1A1 (0.44) | TSHRLMNAALDH1A1 | |
| SCHEMBL31275317 | 0.75 | TSHR (0.40) | TSHRLMNARAB9AHSP90AA1HSP90AB1 | |
| SCHEMBL1149836 | 0.75 | POLA1 (0.35) | LMNA | |
| SCHEMBL1149830 | 0.75 | POLA1 (0.35) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1535895-B1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | SUMITOMO CHEMICAL CO (JP) | 2012-04-25 | — | — | EP | disclosed |
| CN-100341842-C | Process for production of formylcyclopropanecarboxylic ester compound | SUMITOMO CHEMICAL CO (JP) | 2007-10-10 | — | — | CN | disclosed |
| US-20050240050-A1 | Process for production of formylcyclopropanecarboxylic ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-10-27 | — | — | US | disclosed |
| CN-1668570-A | Process for producing formylcyclopropanecarboxylic acid ester compound | SUMITOMO CHEMICAL CO (JP) | 2005-09-14 | — | — | CN | disclosed |
| EP-1535895-A1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | Sumitomo Chemical Company, Limited (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240050-A1 | Process for production of formylcyclopropanecarboxylic ester | AHCYL1, HACL2, CBR1 | TSHR 1259/4885LMNA 4162/4885RAB9A 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.